4 ECTS credits
120 h study time

Offer 1 with catalog number 4023703ENR for all students in the 1st and 2nd semester at a (E) Master - advanced level.

Semester
1st and 2nd semester
Enrollment based on exam contract
Impossible
Grading method
Grading (scale from 0 to 20)
Can retake in second session
Yes
Enrollment Requirements
Je hebt ‘Geïntegreerde farmacologie en farmacotherapie I’ gevolgd, alvorens ‘ Geïntegreerde farmacologie en farmacotherapie II’ op te nemen.
Taught in
Dutch
Faculty
Faculteit Geneeskunde en Farmacie
Department
Faculteit Geneeskunde en Farmacie
Educational team
Stephane Steurbaut
Kristien De Paepe
Santina Gorsen
Sarah Rubens
Gunther Bal
Eline Tommelein (course titular)
Ellen Cogge
Activities and contact hours
18 contact hours Seminar, Exercises or Practicals
72 contact hours Independent or External Form of Study
Course Content

In the course "Integrated practical pharmacology & pharmacotherapy" the student learns to integrate previously acquired knowledge from various course components with new information within real-life practical case studies. The course is offered via blended learning and is structured cyclically:

  1. Each student receives basic material that can be repeated or read through self-study
  2. Each student is evaluated just before the start of each practical session session on the topic of the practical session
  3. During the practical session, the students work in small groups on cases related to the topic of the practical session
  4. After completion of the practical session, the theme of the next practical session is announced and the cycle starts again.

The course consists of six cycles.
 

Additional info

/

Learning Outcomes

General Competencies

This course aims to give students the necessary skills in the integrated approach to practical cases.

Academic Learning Outcomes

  1. The student develops a thorough understanding of the pharmacological principles, mechanisms, and processes underlying the mechanism of action of drugs in the body.
  2. The student is capable of critically analyzing and interpreting pharmacotherapeutical guidelines, taking into account drug-disease interactions and drug-drug interactions.
  3. The student learns to link knowledge and skills from various previous courses.
  4. The student learns how to approach and analyze pharmacotherapeutic practical cases and to identify and solve possible drug-related problems.

Social learning outcomes

  1. The student can efficiently communicate points of concern and/or solutions to drug-related issues to the patient and other healthcare providers.
  2. The student is aware of ethical dilemmas and societal issues related to the use of drugs, such as access to medications, medication costs, and pharmaceutical regulations.

Personal learning outcomes

  1. The student learns to collaborate within a group.
  2. The student learns to test their own insights against those of others and can describe their own functioning within a group.
  3. By collaborating with others and integrating different perspectives, the student develops the ability to think flexibly and find effective pharmacotherapeutic solutions that take into account various viewpoints and treatment options.

Grading

The final grade is composed based on the following categories:
Written Exam determines 50% of the final mark.
Other Exam determines 50% of the final mark.

Within the Written Exam category, the following assignments need to be completed:

  • Schriftelijk examen with a relative weight of 50 which comprises 50% of the final mark.

Within the Other Exam category, the following assignments need to be completed:

  • Permanent Evaluation with a relative weight of 50 which comprises 50% of the final mark.

Additional info regarding evaluation

The assessment consists of the following categories: Evaluation part A “Presence and general attitude during the practical sessions”, Evaluation Part B “Permanent written evaluation of the practice sessions”  and Evaluation part C “Written exam”.


Evaluation part A: Attendance during the practical sessions is mandatory. Absence must be justified by means of an official document.

  • An undocumented absence during the practical sessions leads to failure to pass evaluation part A.
  • In the case of a legitimate absence during a maximum of one practical session, the student must fulfil the test prior to the missed session session at another time during the semester.
  • A legitimate absence for more than one day leads to failure to pass evaluation part A.
  • Attitude during the practical sessions is evaluated through peer evaluation. The students evaluate each other's performance within the group via an online platform. The titular always has the last word and can decide to reinforce, attenuate, or even ignore the result of the peer assessment, if obtained scores prove to be unreliable. In principle, this decision will only be taken in exceptional cases, but will always be based on clear arguments, analyses and / or additional observations / conversations.
  • Failure to pass evaluation part A means referral to the next academic year. Because different skills are tested in the course, this cannot be evaluated in the second examination period: a large part of the design and objectives of this course would be lost.

Evaluation part B: Permanent written evaluation of the practical sessions (50%)

  • Each student is tested just before the start of each practice session regarding the topic of the practice session. The final result is the average of the tests taken.
  • These multiple-choice assessments will be scored using positive scoring with a higher cut-off point. Therefore, no points will be deducted for incorrect answers. However, gaining points through guessing will be factored into the final score by raising the passing threshold (= cut-off point). The cut-off point for the exam and the exact conversion table will be communicated in a timely manner on Canvas and in the exam instructions. The exam strategy with this method is simple: do your best on the entire exam, guess to the best of your ability on questions you do not know or only partially know, without worrying about potential point deductions.
  • Failure to pass evaluation part B means a referral to the second examination period during which all tests within evaluation part B must be retaken.

Evaluation part C: The written exam (50%)

  • The written exam consists of an evaluation of the basic knowledge regarding the topics covered in the practical sessions, as well as the approach to practical case studies on topics covered in the practical sessions.
  • Failure to pass evaluation part C means a reference to the second examination period, in which only Evaluation Part B must be retaken.

Failure to pass evaluation part B or C in the second examination period means a reference to the next academic year, in which only evaluation part B or C respectively must be retaken.

Allowed unsatisfactory mark
The supplementary Teaching and Examination Regulations of your faculty stipulate whether an allowed unsatisfactory mark for this programme unit is permitted.

Academic context

This offer is part of the following study plans:
Master of Pharmaceutical Care: Standaard traject NIEUW (only offered in Dutch)
Master of Drug Development: Pharmacist (only offered in Dutch)
Master of Drug Development: Pharmacist (only offered in Dutch)